Media

Optimizing Success for Community Physicians

Expert pharmacists provide community physicians with recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL).

Fully accessible transcript here.

Limited-Duration Therapy Based on MRD Testing

Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of limited duration therapy.

Fully accessible transcript here.

Developing Clinical Trials for Newly Diagnosed Disease

Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL).

Fully accessible transcript here.

Oral Oncolytics Versus Intravenous: Safety and Efficacy

A comparison of the safety and efficacy of orally and intravenously administered oncolytics.

Fully accessible transcript here.

Oral Therapy Adverse Events

Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists.

Fully accessible transcript here.

Providers – Thank You

A thank you message to all of our providers.

Fully accessible transcript here.